Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 13, keine Gesamtzahl für „Table“
Suchtreffer
Begriffe & Kennungen
Brinavess · 4.8 · Table 1: Adverse reactions a Nervous system Very common: Dysgeusia disorders Common: Paraesthesia; dizziness
Eintrag öffnenBrinavess · 4.8 · a The adverse reactions included in the table occurred within 24 hours of administration of vernakalant (see s
Eintrag öffnenBrineura · 4.8 · 7 Table 2: Frequency of adverse reactions with Brineura
Eintrag öffnenBriumvi · 4.8 · 7 Table 2: Adverse reactions
Eintrag öffnenBriumvi · 4.8 · Table 2 summarises the adverse reactions that have been reported in association with the use of ublituximab. F
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · 7 Table 1: Pharmacokinetic interactions between brivaracetam and other AEDs AED coadministered Influence of AE
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Table 1: Pharmacokinetic interactions between brivaracetam and other AEDs AED coadministered Influence of AED
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Table 1: Pharmacokinetic interactions between brivaracetam and other AEDs AED coadministered Influence of AED
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · In the table below, adverse reactions, which were identified based on review of the three placebo- controlled,
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · In the table below, adverse reactions, which were identified based on review of the three placebo- controlled,
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · In the table below, adverse reactions, which were identified based on review of the three placebo- controlled,
Eintrag öffnenBronchitol · 4.8 · Table 1: Frequency of adverse reactions with Bronchitol in the phase 3 studies (initiation dose assessment and
Eintrag öffnenBronchitol · 4.8 · Table 2: Frequency of adverse reactions with Bronchitol in the phase 3 studies (initiation dose assessment and
Eintrag öffnenBrukinsa · 4.5 · 32 the BRUKINSA dose to 160 mg (one tablet) for the duration of the inhibitor use. Patients should be closely
Eintrag öffnenBrukinsa · 4.8 · 36 Table 4: Adverse reactions of zanubrutinib in combination with obinutuzumab reported in clinical study BGB-
Eintrag öffnenBrukinsa · 4.8 · 9 Table 3: Adverse reactions of zanubrutinib monotherapy reported in clinical studies in patients with B-cell
Eintrag öffnenBrukinsa · 4.8 · Table 3: Adverse reactions of zanubrutinib monotherapy reported in clinical studies in patients with B-cell ma
Eintrag öffnenBrukinsa · 4.8 · Table 4: Adverse reactions of zanubrutinib in combination with obinutuzumab reported in clinical study BGB-311
Eintrag öffnenBuccolam · 4.8 · The table below lists the adverse reactions reported to occur when oromucosal midazolam was administered in cl
Eintrag öffnenBuvidal · 4.8 · 10 Table 2. Adverse reactions listed by body system System Organ Class Very common Common Uncommon Not known
Eintrag öffnen